CYP17 inhibition can result in high ACTH because of inhibited steroidogenesis, which can lead to the formation of excess precursors upstream of CYP17, resulting in mineralocorticoid excess syndrome (MES). Here, CYP17A1 is linked to Meckel syndrome, type 1.